menu search

U.S. FDA panel votes for Pfizer’s RSV vaccine

(Reuters) – A panel of outside advisers to the U.S. Food and Drug Administration (FDA) on Tuesday recommended Pfizer Inc’s respiratory syncytial virus (RSV) vaccine, paving the way for one of the first approved RSV shots in the United States for older adults. The post U.S. FDA panel votes for Pfizer’s RSV vaccine appeared first on ForexTV... Read More
Posted: Feb 28 2023, 23:36
Author Name: forextv
Views: 082246

Search within

Pages Search Results: